Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Change in Acquisitions & Divestments (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Change in Acquisitions & Divestments came in at $159.0 million in Q2 2026, down 78.37% year-over-year from $735.0 million in Q2 2025, and down 23.92% quarter-over-quarter from $209.0 million in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Change in Acquisitions & Divestments across 18 years of filings, most recently posting $159.0 million for Q2 2026.

  • In Q2 2026, Change in Acquisitions & Divestments fell 78.37% year-over-year to $159.0 million; the TTM figure through Jun 2026 stood at $1.1 billion (down 37.04% YoY), while the FY2025 annual figure was $1.7 billion, down 32.53% from the prior year.
  • Change in Acquisitions & Divestments came in at $159.0 million for Q2 2026 at Johnson & Johnson, down from $209.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $24.8 billion in Q1 2023 to a low of $159.0 million in Q2 2026.
  • Average Change in Acquisitions & Divestments over 5 years is $3.4 billion, with a median of $731.0 million recorded in 2024.
  • Year-over-year, Change in Acquisitions & Divestments grew 23.21% in 2023 and slumped 91.95% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $6.3 billion in 2022, then tumbled by 42.84% to $3.6 billion in 2023, then tumbled by 91.95% to $290.0 million in 2024, then dropped by 24.48% to $219.0 million in 2025, then dropped by 27.4% to $159.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $159.0 million in Q2 2026, $209.0 million in Q1 2026, and $219.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 159.00 Mn
Mar 29, 2026 209.00 Mn
Dec 28, 2025 219.00 Mn
Sep 28, 2025 489.00 Mn
Jun 29, 2025 735.00 Mn
Mar 30, 2025 218.00 Mn
Dec 29, 2024 290.00 Mn
Sep 29, 2024 466.00 Mn
Jun 30, 2024 727.00 Mn
Mar 31, 2024 979.00 Mn
Dec 31, 2023 3.60 Bn
Oct 1, 2023 3.91 Bn
Jul 2, 2023 4.11 Bn
Apr 2, 2023 7.77 Bn
Jan 1, 2023 24.80 Bn
Apr 3, 2022 6.30 Bn
Oct 3, 2021 4.36 Bn
Jul 4, 2021 7.22 Bn
Apr 4, 2021 5.23 Bn
Jan 3, 2021 5.55 Bn